FDA to review new oral gonorrhea antibiotic
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 Drugmaker Innoviva Specialty Therapeutics announced today that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for zoliflodacin, an investigational oral antibiotic for uncomplicated gonorrhea. If the FDA approves the drug, it would be the first new antibiotic for gonorrhea in decades and a much-needed weapon against the second most common sexually transmitted infection in the world. Gonorrhea causes an
